Previous 10 | Next 10 |
Placentia, California--(Newsfile Corp. - November 16, 2022) - InVitro International (OTC Pink: IVRO) today announced it has signed its first Letter of Intent (LOI) to acquire a privately owned, U.S. based testing laboratory. Over many years this laboratory has served IVRO targeted markets prof...
Placentia, California--(Newsfile Corp. - August 10, 2022) - InVitro International (OTC Pink: IVRO) today announced year to date Fiscal Year '22, and 3 rd quarter financial results. Following a 2 nd fiscal quarter sales advance of 27%, 3 rd quarter sales slid 23%, leaving year to date sales ...
Placentia, California--(Newsfile Corp. - April 26, 2022) - InVitro International (OTC PINK: IVRO), an established leader in advancing NON-Animal testing technologies, today announced fiscal 2022 year to date and second fiscal quarter financial results. Second quarter sales of $260,219 were up ...
Placentia, California--(Newsfile Corp. - March 30, 2022) - InVitro International (OTC PINK: IVRO), a 30+ year leader in providing non-animal testing methods, today announced it has completed the re-purchase of 100,000 shares of its common stock. The terms of this transaction were negotiated in...
Placentia, California--(Newsfile Corp. - February 14, 2022) - InVitro International (OTC Pink: IVRO), a leading provider of non-animal testing methods, today announced revenues of $183,561 and net income of $56,940 for its first fiscal quarter of 2022, ending December 31, 2021, compared to rev...
InVitro International (OTCPK:IVRO): FY GAAP EPS of $0.004. Revenue of $1M (-9.1% Y/Y) Press Release Financial Statement For further details see: InVitro International reports FY results
Placentia, California--(Newsfile Corp. - December 8, 2021) - InVitro International (OTC Pink: IVRO) announced today that fiscal year 2021 sales for the year ending on September 30th topped $1M for the third consecutive year at $1,003,403. Though off 9% for the year, second half sales were up 4...
PLACENTIA, CA / ACCESSWIRE / September 1, 2021 / InVitro International (OTC PINK:IVRO) announced today that it has taken a first step in its search for strategic partners. IVRO entered into Letter of Intent (LOI) discussions where, although nothing certain can be forecasted, the Company beli...
PLACENTIA, CA / ACCESSWIRE / August 4, 2021 / InVitro International (OTC PINK:IVRO) is pleased to announce FY 2021 3 rd quarter revenues of $310,700 and net income of $87,644. These sales were 35%+ vs same quarter FY '20, and 51% ahead of 2 nd quarter sales this year. Net income YTD in FY ...
Placentia, California--(Newsfile Corp. - May 25, 2021) - InVitro International, Inc. (OTC Pink: IVRO) today announced the appointment of Investor Relations Partners (IRP) to provide external investor relations services to InVitro. IRP is an investor relations and public relations firm repre...
News, Short Squeeze, Breakout and More Instantly...
Placentia, California--(Newsfile Corp. - May 2, 2024) - Today, InVitro International (OTC Pink: IVRO), announced second quarter FY '24 sales of $210,615, up 5.8% compared to $199,090 for the same period FY '23. Net income in the quarter was $47,674 versus losses of $3,356 in '23. First half FY '2...
Placentia, California--(Newsfile Corp. - February 14, 2024) - Today, InVitro International (OTC Pink: IVRO), the 38-year-old pioneer developer and marketer of globally approved NON-Animal test technologies, announced first Quarter FY '24 sales ending December 31, 2023, of $211,625 up 1.1% vs. the...
Placentia, California--(Newsfile Corp. - November 13, 2023) - Today, InVitro International (OTC Pink: IVRO), the 38-year-old pioneer developer and marketer of globally approved NON-Animal test technologies, announced sales for FY '23 ending September 30, 2023 of $792,629 ( -7% vs FY '22); net inc...